These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17594992)

  • 21. [Substitutions therapy of opiate addiction in Denmark].
    Ishøy T; Iversen C
    Ugeskr Laeger; 2003 Sep; 165(38):3620-3. PubMed ID: 14556394
    [No Abstract]   [Full Text] [Related]  

  • 22. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid maintenance: the politics matter.
    Sindelar JL
    Addiction; 2001 Oct; 96(10):1517-8. PubMed ID: 11599514
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.
    Soeffing JM; Martin LD; Fingerhood MI; Jasinski DR; Rastegar DA
    J Subst Abuse Treat; 2009 Dec; 37(4):426-30. PubMed ID: 19553061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment considerations in the opioid dependent patient.
    Wartenberg AA
    Med Health R I; 1999 Mar; 82(3):91-4. PubMed ID: 10193138
    [No Abstract]   [Full Text] [Related]  

  • 27. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
    Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of methadone program philosophy changes on early treatment outcomes.
    Brands B; Blake J; Marsh D
    J Addict Dis; 2003; 22(3):19-38. PubMed ID: 14621342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian nonparametric approach to analysis of treatment for drug-dependence data.
    Tiwari RC
    NIDA Res Monogr; 1992; 128():70-81. PubMed ID: 1436017
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
    Winstock AR; Lea T; Sheridan J
    Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of buprenorphine maintenance versus methadone maintenance.
    French MT
    Addiction; 2001 Oct; 96(10):1515-7. PubMed ID: 11599513
    [No Abstract]   [Full Text] [Related]  

  • 33. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Problems with maintenance therapy in opiate dependence and the clinical importance of methadone].
    Wilczek H
    Cas Lek Cesk; 1998 Nov; 137(23):725-8. PubMed ID: 9990177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
    Madden A; Lea T; Bath N; Winstock AR
    Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance.
    Caplehorn J; Deeks JJ
    Drug Alcohol Rev; 2006 Mar; 25(2):157-60. PubMed ID: 16627305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
    Lawrinson P; Ali R; Buavirat A; Chiamwongpaet S; Dvoryak S; Habrat B; Jie S; Mardiati R; Mokri A; Moskalewicz J; Newcombe D; Poznyak V; Subata E; Uchtenhagen A; Utami DS; Vial R; Zhao C
    Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comment to a contribution on methadone program in Stockholm].
    Eriksson N
    Lakartidningen; 2001 Dec; 98(50):5797. PubMed ID: 11789109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.